dc.creator | Liakopoulos V., Stefanidis I., Mertens P.R. | en |
dc.date.accessioned | 2023-01-31T08:50:17Z | |
dc.date.available | 2023-01-31T08:50:17Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1053/j.ajkd.2018.01.053 | |
dc.identifier.issn | 02726386 | |
dc.identifier.uri | http://hdl.handle.net/11615/75810 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | American Journal of Kidney Diseases | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053831552&doi=10.1053%2fj.ajkd.2018.01.053&partnerID=40&md5=ae9ca38bcee6d83c0e0d19e0609743ed | |
dc.subject | icodextrin | en |
dc.subject | dialysis fluid | en |
dc.subject | icodextrin | en |
dc.subject | early intervention | en |
dc.subject | health care facility | en |
dc.subject | human | en |
dc.subject | kidney failure | en |
dc.subject | Letter | en |
dc.subject | medical decision making | en |
dc.subject | peritoneal dialysis | en |
dc.subject | prescription | en |
dc.subject | renal clearance | en |
dc.subject | risk assessment | en |
dc.subject | survival rate | en |
dc.subject | treatment failure | en |
dc.subject | treatment outcome | en |
dc.subject | ultrafiltration | en |
dc.subject | Australia | en |
dc.subject | hemodialysis | en |
dc.subject | New Zealand | en |
dc.subject | register | en |
dc.subject | Australia | en |
dc.subject | Dialysis Solutions | en |
dc.subject | Humans | en |
dc.subject | Icodextrin | en |
dc.subject | New Zealand | en |
dc.subject | Peritoneal Dialysis | en |
dc.subject | Registries | en |
dc.subject | Renal Dialysis | en |
dc.subject | W.B. Saunders | en |
dc.title | The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis | en |
dc.type | other | en |